Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,239,092
+$295,819 QoQ
Shares Held
8,898
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.15%
of 13F equity value
Holder Rank
#1,874
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AFFINITY INVESTMENT ADVISORS, LLC holds $11,731,822 across 9 Drug Manufacturers - General names. ABBV ranks #1 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
8,898 | $2,239,092 | |
| 2 | JNJ |
Johnson & Johnson
|
8,462 | $2,149,094 | |
| 3 | PFE |
Pfizer Inc
|
79,689 | $1,918,911 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
30,557 | $1,760,694 | |
| 5 | AMGN |
Amgen Inc
|
4,328 | $1,567,255 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,172 | $921,602 | |
| 7 | LLY |
ELI LILLY & Co
|
360 | $431,794 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,040 | $384,073 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,239,092 | 8,898 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,943,273 | 8,935 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,040,187 | 8,929 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,083,165 | 8,997 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,698,608 | 9,151 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,978,706 | 9,444 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,820,714 | 10,246 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,462,180 | 12,468 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $2,179,676 | 12,708 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,314,126 | 12,708 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,724,196 | 11,126 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,795,278 | 12,044 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $1,669,035 | 12,388 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,551,513 | 16,010 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $3,425,970 | 21,199 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,049,116 | 22,719 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,561,735 | 23,255 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $3,844,924 | 23,718 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $3,607,868 | 26,646 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,896,848 | 26,855 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,020,892 | 26,819 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $4,628,461 | 42,769 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,617,307 | 43,092 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,694,458 | 42,179 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,821,067 | 38,919 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,987,333 | 39,209 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||